Medifast, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $96.0M | $52.4M |
| FY2017 | — | $106.6M | $75.1M |
| FY2018 | — | $109.1M | $81.4M |
| FY2019 | — | $104.8M | $77.0M |
| FY2020 | — | $157.2M | $163.7M |
| FY2021 | — | $202.5M | $104.2M |
| FY2022 | — | $155.0M | $87.7M |
| FY2023 | — | $201.5M | $94.4M |
| FY2024 | — | $210.1M | $90.9M |
| FY2025 | — | $198.9M | $89.3M |